These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3032112)

  • 1. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
    Akamatsu K; Miyauchi S; Yasuhara Y; Mogami H; Nishimura N; Ohshima K; Ohta Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of gallbladder complications by treatment of hepatic arterial embolization with caerulein.
    Akamatsu K; Miyauchi S; Ohshima K; Okita S; Yasuhara Y; Mogami H; Ohta Y; Hamamoto K
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S59-64. PubMed ID: 2538268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.
    Kuroda C; Iwasaki M; Tanaka T; Tokunaga K; Hori S; Yoshioka H; Nakamura H; Sakurai M; Okamura J
    Radiology; 1983 Oct; 149(1):85-9. PubMed ID: 6310685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder infarction after hepatic artery embolization.
    Takayasu K; Moriyama N; Muramatsu Y; Shima Y; Ushio K; Yamada T; Kishi K; Hasegawa H
    AJR Am J Roentgenol; 1985 Jan; 144(1):135-8. PubMed ID: 2981123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
    Kishimoto W; Nakao A; Takagi H; Hayakawa T
    Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Yeh SH
    Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Temporary placement of inferior vena cava filter prior to transcatheter arterial embolization (TAE) for hepatocellular carcinoma with IVC tumor thrombus--prevention of pulmonary tumor emboli after TAE].
    Izaki K; Matsumoto S; Konishi J; Higashino T; Tsurusaki M; Fukuda T; Akasaka Y; Mori T; Sugimoto K; Fujii M; Sugimura K; Yoshikawa T; Hirota S; Hayashi Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1708-11. PubMed ID: 11708015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The change of hepatic energy status after transcatheter arterial embolization (TAE) for hepatocellular carcinoma--a study using 31P-MRS].
    Taniguchi K; Kaminaga T; Sakon M; Umeshita K; Yamada T; Takeda Y; Higaki N; Aoki T; Ohzato H; Hasuike Y; Gotoh M; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1632-4. PubMed ID: 9382494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
    Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcatheter arterial chemoembolization and selective hepatic arterial infusion using totally implantable reservoir].
    Sakurai Y; Kodaira S; Teramoto T; Miyajima N; Kuzuoka M; Ishii T; Arisawa Y; Takabayashi T; Abe O
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2473-8. PubMed ID: 3415258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of porous gelatin sphere (YM 670) in transcatheter arterial embolization].
    Yamada R; Sawada S; Uchida H; Kumazaki T; Hiramatsu K; Ishii H; Nakao N; Nakamura H; Taguchi T
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1431-6. PubMed ID: 16227743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE].
    Itsubo M; Koike K; Toda G
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
    Motohara T; Ozawa Z; Morita S
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes.
    Wang Y; Zhang J; Gao Y; Yu M; Gong Y; Yu G
    Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
    Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
    Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.